首页|乳腺癌化疗患者自我倡权能力与症状负担的相关性

乳腺癌化疗患者自我倡权能力与症状负担的相关性

扫码查看
目的 调查乳腺癌化疗患者自我倡权能力与症状负担现状,并探讨二者之间的相关性,为减轻乳腺癌化疗患者的症状负担提供参考.方法 采用一般资料调查表、女性癌症幸存者自我倡权量表及中文版安德森症状评估量表(M D Anderson symptom inventory,MDASI),对湖北省某三级甲等医院 260 例乳腺癌化疗患者进行问卷调查,采用Pearson相关分析自我倡权能力与症状负担的相关性,采用分层回归分析自我倡权能力对症状负担的影响.结果 240 例患者完成研究.乳腺癌化疗患者自我倡权能力总分(68.89±10.66)分,处于中等水平,症状负担总分(66.70±18.80)分,整体症状水平介于轻度到中度之间,各症状发生率多高于 50.00%.自我倡权能力与症状负担呈负相关(r=-0.683,P<0.05),分层回归结果显示,自我倡权能力可独立解释症状负担总变异的 9.3%.结论 乳腺癌化疗患者各种不适症状发生率高,且多种症状并存,症状负担与自我倡权能力呈负相关,强化患者的自我倡权能力有助于减轻其症状负担.
Correlations between self-advocacy and symptom burden of breast cancer patients undergoing chemotherapy
Objective To investigate the status of self-advocacy and symptom burden in breast cancer patients undergoing chemotherapy and explore the correlations between them so as to provide a reference for relieving their symptom burden.Methods A total of 240 breast cancer patients undergoing chemotherapy who were treated in a general hospital in Hubei province from July 2021 to January 2022 were enrolled in the study by convenience sampling method.The general data questionnaire,female self-advocacy in cancer survivorship scale,and Chinese version of Anderson symptom assessment scale(MDASI)were applied in the investigation.Pearson correlation analysis was employed to explore the correlation between self-advocacy and symptom burden among breast cancer patients undergoing chemotherapy.Hierarchical regression was employed to analyze the effect of self-advocacy on symptom burden.Results A total of 240 patients completed the study.The total score of self-advocacy of the patients was(68.89±10.66),and the total score of symptom burden was(66.70±18.80).The two variables were significantly correlated in a negative way(r=-0.683,P<0.05).Hierarchical regression showed that self-advocacy ability independently explained 9.3%of the total variation in the symptom burden.Conclusions The incidences of various symptoms in breast cancer patients undergoing chemotherapy are high,and multiple symptoms coexist in the whole chemotherapy cycle.Symptom burden cannot be ignored,for it is negatively correlated with self-advocacy.Therefore,strengthening the concept and ability of self-advocacy can help reduce symptom burden of patients.

breast cancerchemotherapyself-advocacysymptom burdenquality of lifecross-sectional study

何丽、胡露红、王玮荻、王倩云

展开 >

浙江树人大学树兰国际医学院,浙江杭州,310015

华中科技大学同济医学院附属同济医院,湖北武汉, 430030

乳腺癌 化疗 自我倡权 症状负担 生活质量 横断面研究

湖北省卫生健康委2021-2022年面上项目

WJ2021M118

2024

现代临床护理
中山大学

现代临床护理

CSTPCD
影响因子:1.317
ISSN:1671-8283
年,卷(期):2024.23(1)
  • 25